Drugs / Small Mobile Stem Cells
last change 17 days ago re-read 3 minutes ago

Small Mobile Stem Cells

also known as SMS cells
Developed for
chronic obstructive pulmonary disease
Investigated by
SMSbiotech

Trials 1

20262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT06986070 Jun 2025 → Dec 2026 expected chronic obstructive pulmonary disease SMSbiotech Recruiting No outcome recorded

News releases announcing trial results or a regulatory action · 13

DateIssuerRelease
2026-09-16 SMSbiotech Regulatory SMSbiotech Advances COPD Program with U.S. FDA Clearance of IND smsbiotech.com ↗
SMSbiotech, Inc., a clinical-stage regenerative-medicine company advancing Small Mobile Stem (SMS) Cells as a first-in-class nebulized stem cell therapy for COPD and other diseases with high unmet medical need, today announced that the U.S. Food and Drug Administration (FDA) has completed its review of the Company’s Investigational New Drug (IND) application and issued a "Study May Proceed" notification.
2025-11-12 SMSbiotech Results European Society of Medicine Publishes Groundbreaking Article on Small Mobile Stem Cells smsbiotech.com ↗
The European Society of Medicine has published a new peer-reviewed article highlighting the transformative potential of Small Mobile Stem (SMS) cells —a discovery that could redefine the future of regenerative medicine.
2025-10-29 SMSbiotech Results Regenerative Breakthrough in Canine Wound Healing smsbiotech.com ↗
Within one week of systemic SMS cell administration, the wound site exhibited rapid granulation, new tissue formation, and clear signs of recovery.
2025-10-15 SMSbiotech Results Breakthrough Study in Horses Reinforces SMS Cell Therapy’s Platform Versatility smsbiotech.com ↗
The study demonstrated remarkable tendon repair , with evidence of restored tissue structure and function across multiple treated horses.
2025-07-09 SMSbiotech Results SMS Cells After RF Microneedling: New Evidence Shows Faster Recovery & Better Skin Quality smsbiotech.com ↗
In a clinical evaluation, a topical SMS cell suspension applied immediately after SYLFIRM X™ RF microneedling produced exceptional results: every patient experienced complete resolution of post-procedural redness in under an hour, compared to the typical 24-hour recovery period.
2024-07-09 SMSbiotech Results A Breakthrough in COPD Regeneration: How Small Mobile Stem (SMS) Cells Transform Lung Repair smsbiotech.com ↗
Most strikingly, in a COPD proof-of-concept study, rats with elastase-induced emphysema experienced rapid and complete lung regeneration within two weeks following SMS cell delivery into the respiratory tract.
2022-06-24 SMSbiotech Results 4th Annual Longevity Therapeutics Summit smsbiotech.com ↗
On June 29th, 2022 at 3:30 pm, Dr. Abdulkader Rahmo (CSO SMSbiotech) presented “ Small Mobile Stem Cells Regenerating Lung Alveoli Exceeding Same Age Control Values ” in the Poster Networking Session.
2021-09-21 SMSbiotech Results SMSbiotech Successfully Completes First Test of a Series of Animal Studies for COPD Treatment smsbiotech.com ↗
The first test of this series has concluded and indicates the strong safety pattern associated with the direct application of Small Mobile Stem (SMS) cells to the lungs.
2021-06-29 SMSbiotech Results American Chemical Society Fall 2021 Presentation smsbiotech.com ↗
The result of this study demonstrates a substantial effect on a wide array of genes (1310 genes), many of which are currently proposed or investigated as targets for drug treatment of lung degenerative diseases.
2021-03-02 SMSbiotech Results In Vitro Gene Expression Study Demonstrates Small Mobile Stem Cells Stimulate Progenitor Lung Cells smsbiotech.com ↗
Results indicate that SMS cells induce important changes to gene expression, upregulating pro-regenerative gene expression, pathogen protection, and lung integrity, while suppressing certain inflammatory and necrotic pathways.
2019-11-06 SMSbiotech Results Breakthrough in Angiogenesis: Small Mobile Stem Cells Drive Large Vessel Formation smsbiotech.com ↗
2015-03-26 SMSbiotech Results 5th World Congress on Cell & Stem Cell Research, 2015 smsbiotech.com ↗
Results indicate the importance of implicating the M3 mediated mechanism in native tissue reconstruction; and demonstrate hence the fundamental role of Native Adult SMS Cells

All press releases naming this drug 18 releases

DateIssuerRelease

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Small Mobile Stem Cells “Participants will be treated with the study drug, SORT COPD (Small Mobile Stem Cells), delivered via a medical nebuliser” NCT06986070 ↗
Known as SMS cells “treated with SORT-COPD (SMS cells).” NCT06986070 ↗
Route Inhaled “through inhalation” NCT06986070 ↗